Plain-English translation of NCT06573450 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for biological markers—measurable signs in your blood and breath—that could help doctors better understand and diagnose combined allergic rhinitis and asthma. This study compares samples from healthy people and people at different stages of these conditions to find patterns that might lead to better, more personalized care.
Current ways of diagnosing these conditions rely on symptoms and general tests, but doctors need more objective, straightforward methods to identify who has the disease and what stage they're in. By analyzing breath and blood samples, researchers hope to discover new markers that could make diagnosis more accurate and help guide individual treatment plans.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic to have your medical history recorded, provide a blood sample, and provide a breath sample (collected by breathing into a special container). There is no medication to take and no experimental treatment involved—this is purely a sample collection study. The entire process is designed to be simple and non-invasive.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China
Sponsor
Henan University of Traditional Chinese Medicine
Enrollment target
~270 participants
Started
April 2023
Primary completion
May 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yang Xie
Henan University of Traditional Chinese Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.